{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Déficit immunitaire commun variable : Questions médicales les plus fréquentes",
"headline": "Déficit immunitaire commun variable : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Déficit immunitaire commun variable : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-01",
"dateModified": "2026-03-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Déficit immunitaire commun variable"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Déficits immunitaires",
"url": "https://questionsmedicales.fr/mesh/D007153",
"about": {
"@type": "MedicalCondition",
"name": "Déficits immunitaires",
"code": {
"@type": "MedicalCode",
"code": "D007153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.673"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Déficit immunitaire commun variable",
"alternateName": "Common Variable Immunodeficiency",
"code": {
"@type": "MedicalCode",
"code": "D017074",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Charlotte Cunningham-Rundles",
"url": "https://questionsmedicales.fr/author/Charlotte%20Cunningham-Rundles",
"affiliation": {
"@type": "Organization",
"name": "Icahn School of Medicine at Mount Sinai, Division of Allergy and Clinical Immunology, Department of Medicine, New York, New York."
}
},
{
"@type": "Person",
"name": "Reza Yazdani",
"url": "https://questionsmedicales.fr/author/Reza%20Yazdani",
"affiliation": {
"@type": "Organization",
"name": "Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Hassan Abolhassani",
"url": "https://questionsmedicales.fr/author/Hassan%20Abolhassani",
"affiliation": {
"@type": "Organization",
"name": "Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Asghar Aghamohammadi",
"url": "https://questionsmedicales.fr/author/Asghar%20Aghamohammadi",
"affiliation": {
"@type": "Organization",
"name": "Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran, aghamohammadi@sina.tums.ac.ir."
}
},
{
"@type": "Person",
"name": "Hsi-En Ho",
"url": "https://questionsmedicales.fr/author/Hsi-En%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Industry 5 and the Human in Human-Centric Manufacturing.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37514710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23146416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Déficits immunitaires",
"item": "https://questionsmedicales.fr/mesh/D007153"
},
{
"@type": "ListItem",
"position": 4,
"name": "Déficit immunitaire commun variable",
"item": "https://questionsmedicales.fr/mesh/D017074"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Déficit immunitaire commun variable - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Déficit immunitaire commun variable",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Déficit immunitaire commun variable",
"description": "Comment diagnostique-t-on le DICV ?\nQuels tests sont utilisés pour le DICV ?\nLe DICV peut-il être confondu avec d'autres maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes tests génétiques sont-ils nécessaires pour le DICV ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Déficit immunitaire commun variable",
"description": "Quels sont les symptômes courants du DICV ?\nLe DICV provoque-t-il des symptômes auto-immuns ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nY a-t-il des signes d'alerte pour le DICV ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Déficit immunitaire commun variable",
"description": "Comment prévenir les infections chez les patients DICV ?\nLes vaccinations sont-elles recommandées ?\nLe mode de vie influence-t-il la prévention ?\nLes patients doivent-ils éviter certains environnements ?\nDes conseils spécifiques existent-ils pour les patients ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Déficit immunitaire commun variable",
"description": "Quel est le traitement principal du DICV ?\nDes médicaments immunosuppresseurs sont-ils utilisés ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nComment surveille-t-on l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Déficit immunitaire commun variable",
"description": "Quelles sont les complications possibles du DICV ?\nLe DICV augmente-t-il le risque de cancer ?\nComment les infections chroniques affectent-elles la vie ?\nLes maladies auto-immunes sont-elles fréquentes ?\nComment gérer les complications du DICV ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Déficit immunitaire commun variable",
"description": "Quels sont les facteurs de risque du DICV ?\nLe sexe influence-t-il le risque de DICV ?\nL'âge joue-t-il un rôle dans le DICV ?\nLes infections précoces augmentent-elles le risque ?\nY a-t-il des facteurs environnementaux associés ?",
"url": "https://questionsmedicales.fr/mesh/D017074?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le DICV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour évaluer les niveaux d'anticorps et l'historique médical."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le DICV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la mesure des immunoglobulines et des tests de stimulation lymphocytaire."
}
},
{
"@type": "Question",
"name": "Le DICV peut-il être confondu avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres immunodéficiences ou maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les infections récurrentes et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires pour le DICV ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests génétiques ne sont pas toujours nécessaires, mais peuvent aider dans certains cas."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du DICV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des infections fréquentes, des problèmes respiratoires et des diarrhées."
}
},
{
"@type": "Question",
"name": "Le DICV provoque-t-il des symptômes auto-immuns ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des symptômes auto-immuns comme l'arthrite ou des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître à tout âge, souvent entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte pour le DICV ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections récurrentes et des maladies auto-immunes sont des signes d'alerte importants."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections chez les patients DICV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la vaccination, l'hygiène rigoureuse et l'évitement des foules."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations sont recommandées, mais certaines doivent être évitées selon le cas."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une alimentation équilibrée, aide à renforcer l'immunité."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains environnements ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les environnements à risque élevé d'infection est conseillé."
}
},
{
"@type": "Question",
"name": "Des conseils spécifiques existent-ils pour les patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils incluent l'évitement des personnes malades et le port de masques en public."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du DICV ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'immunoglobuline intraveineuse ou sous-cutanée pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Des médicaments immunosuppresseurs sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments immunosuppresseurs peuvent être prescrits pour traiter les maladies auto-immunes associées."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement à vie pour maintenir une immunité adéquate."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent inclure des réactions allergiques et des infections."
}
},
{
"@type": "Question",
"name": "Comment surveille-t-on l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est surveillée par des tests sanguins réguliers et l'évaluation des infections."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du DICV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections chroniques, des maladies auto-immunes et des cancers."
}
},
{
"@type": "Question",
"name": "Le DICV augmente-t-il le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients DICV ont un risque accru de certains types de cancer, notamment lymphomateux."
}
},
{
"@type": "Question",
"name": "Comment les infections chroniques affectent-elles la vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections chroniques peuvent entraîner une fatigue, des hospitalisations fréquentes et une qualité de vie réduite."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes sont fréquentes chez les patients DICV, affectant divers systèmes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du DICV ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier, des traitements appropriés et un soutien psychologique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du DICV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de DICV ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le DICV est plus fréquent chez les hommes que chez les femmes, bien que les deux sexes soient touchés."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le DICV ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que le DICV puisse survenir à tout âge, il est souvent diagnostiqué chez les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Les infections précoces augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections précoces dans l'enfance peuvent être un facteur de risque pour le DICV."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux associés ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux, comme l'exposition à des agents infectieux, peuvent jouer un rôle."
}
}
]
}
]
}
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran.
Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Déficit immunitaire commun variable" :
Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Primary Immunodeficiency, Iran University of Medical Sciences, Tehran, Iran.
Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at the Karolinska University Hospital Huddinge, Stockholm, Sweden.
Publications dans "Déficit immunitaire commun variable" :
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran, aghamohammadi@sina.tums.ac.ir.
Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran, aghamohammadi@sina.tums.ac.ir.
Publications dans "Déficit immunitaire commun variable" :
1Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
Publications dans "Déficit immunitaire commun variable" :
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran.
Publications dans "Déficit immunitaire commun variable" :
Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Institute for Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; DZIF - German Center for Infection Research, Satellite Center Freiburg, Germany; CIBSS - Centre for Integrative Biological Signalling Studies, Albert-Ludwigs University, Freiburg, Germany; RESIST - Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg, Germany.
Publications dans "Déficit immunitaire commun variable" :
1Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
Publications dans "Déficit immunitaire commun variable" :
1Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
Publications dans "Déficit immunitaire commun variable" :
1Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
Publications dans "Déficit immunitaire commun variable" :
Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica. Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.
Publications dans "Déficit immunitaire commun variable" :
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...
All human groups are equally human, but are they automatically represented as such? Harnessing data from 61,377 participants across 13 experiments (six primary and seven supplemental), a sharp dissoci...
Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure,...